Drug profile · INN
sonidegib phosphate
ODOMZO
sonidegib phosphate (ODOMZO) is a smoothened homolog inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — sonidegib phosphate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
sonidegib phosphate (ODOMZO) is a smoothened homolog inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Smoothened homolog inhibitor
Primary target: Protein smoothened
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is sonidegib phosphate?
sonidegib phosphate (ODOMZO) is a smoothened homolog inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for sonidegib phosphate?
ODOMZO is a marketed brand name for sonidegib phosphate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sonidegib phosphate?
sonidegib phosphate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.